Katka Franke
Company: CureVac
Job title: Senior Director Cancer Antigen Discovery & Validation
Seminars:
Chair’s Opening Remarks 8:50 am
day: Day Two
Panel Discussion: Validating Immunogenicity of Neoantigens & Establishing a Consensus on Selecting Optimal Neoantigen Targets to Generate an Efficacious Immune Response 12:00 pm
Developing a robust, functional validation platform using effector T-cells to validate neoantigen immunogenicity and avoid systemic toxicity Establishing a consensus on the most appropriate tools and technologies for ranking and selecting the best neoantigens for targeting Characterising neoantigens and selecting an appropriate number for use in therapies to invoke immunogenicity in patientsRead more
day: Day One